09.11.2022 12:58:47
|
ANI Pharmaceuticals, Inc. Q3 Earnings Summary
(RTTNews) - Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):
Earnings: -$9.01 million in Q3 vs. -$4.45 million in the same period last year. EPS: -$0.55 in Q3 vs. -$0.37 in the same period last year. Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $10.38 million or $0.64 per share for the period.
Analysts projected $0.55 per share Revenue: $83.82 million in Q3 vs. $52.06 million in the same period last year.
-Guidance: Full year EPS guidance: $1.34 - $1.62 Full year revenue guidance: $295 - $315 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Biosante Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Biosante Pharmaceuticals Inc | 51,00 | 0,00% |
|